Clinical Trials on Bladder Urothelial Carcinoma
Total 25672 results
-
IRCCS San RaffaeleRecruiting
-
CG Oncology, Inc.TerminatedCarcinoma in Situ | Transitional Cell Carcinoma | Bladder Cancer | Carcinoma in Situ Concurrent With Papillary TumorsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Carcinoma | Stage I Bladder Cancer AJCC v6 and v7 | Stage II Bladder Cancer AJCC v6 and v7 | Stage III Bladder Cancer AJCC v6 and v7United States
-
Associació per a la Recerca Oncologica, SpainUnknownUrothelium Transitional Cell CarcinomaSpain, Netherlands
-
Achieve Life SciencesPRA Health SciencesCompletedUrologic Neoplasms | Metastatic Bladder Cancer | Urinary Tract NeoplasmsSpain, United States, Canada, Italy, Poland, Germany, France
-
AIO-Studien-gGmbHAstraZenecaCompletedCholangiocarcinoma | Cholangiocarcinoma Non-resectable | Gall Bladder Carcinoma | Gallbladder Carcinoma Non-ResectableGermany
-
Achieve Life SciencesCompletedCarcinoma, Transitional Cell | Ureteral Neoplasms | Urethral Neoplasms | Bladder NeoplasmsUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedBladder CarcinomaUnited States
-
LanZhou UniversityCompleted
-
Assiut UniversityNot yet recruitingUrinary Bladder Squamous Cell Carcinoma
-
Peking University First HospitalPeking University First Hospital Miyun HospitalNot yet recruiting
-
Association of Urologic Oncology (AUO)Eli Lilly and CompanyUnknownCarcinoma, Transitional Cell | Bladder CancerGermany
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Urothelial Carcinoma | Myeloproliferative DisorderUnited States
-
Matthew Milowsky, MDHoosier Cancer Research Network; Bladder Cancer Advocacy Network (BCAN®)CompletedBladder Cancer | Urothelial Carcinoma | Urethral Cancer | Cancer of the UreterUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Unknown
-
European Organisation for Research and Treatment...Terminated
-
AHS Cancer Control AlbertaCross Cancer InstituteCompletedBladder Carcinoma | Small Cell Carcinoma | Lung NeoplasmCanada
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Fox Chase Cancer CenterTerminatedStage III Bladder Cancer | Distal Urethral Cancer | Proximal Urethral Cancer | Squamous Cell Carcinoma of the Bladder | Urethral Cancer Associated With Invasive Bladder Cancer | Stage II Bladder CancerUnited States
-
Institute of Cancer Research, United KingdomCompletedBladder CancerUnited Kingdom
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional...Canada
-
Incyte CorporationCompletedHead and Neck Cancer | Gastric Cancer | Lung Cancer | Metastatic Cancer | Mesothelioma | Bladder Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Colorectal Cancer (CRC) | UC (Urothelial Cancer)Italy, Spain, United States, Netherlands
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingAdrenocortical Carcinoma | Penile Cancer | Genitourinary Cancer | Non-urothelial Bladder | Non-urothelial Upper Tract | Non-adenocarcinoma Prostate Cancer | Refractory Germ-cell | High Grade Neuroendocrine Carcinoma/Small Cell CarcinomaUnited States
-
Spanish Oncology Genito-Urinary GroupBristol-Myers SquibbRecruiting
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingUrothelial CancerUnited States, Argentina, Australia, Belgium, Canada, China, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Singapore, Spain, Switzerland, Taiwan, Thailand and more
-
Fundacion CRIS de Investigación para Vencer el...GlaxoSmithKline; Apices Soluciones S.L.; IpsenActive, not recruiting
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingUrothelial CancerGermany, Switzerland
-
University of ChicagoCompletedUrothelial CancerUnited States
-
Roswell Park Cancer InstituteRecruitingUrinary Tract Infection | Bladder Carcinoma | Refractory Bladder CarcinomaUnited States
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
Qilu Pharmaceutical Co., Ltd.RecruitingMelanoma | Urothelial CarcinomaChina
-
Apexigen America, Inc.CompletedMelanoma | Cancer | Head and Neck Cancer | NSCLC | Urothelial Carcinoma | MSI-HUnited States
-
Fundacio PuigvertNucleix Ltd.UnknownUrologic Neoplasms | Urologic CancerSpain
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedMetastatic Transitional Cell Carcinoma of the UrotheliumUnited States
-
Seth LernerAstraZeneca; Cytogen CorporationCompletedUrinary Bladder NeoplasmsUnited States, Italy
-
University of Texas Southwestern Medical CenterCompletedMelanoma | Urothelial Carcinoma | Cervical Carcinoma in SituUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrothelial CancerRussian Federation, United States, Brazil, Spain, Chile, Korea, Republic of, Argentina, Australia, Canada, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Italy, Japan, Mexico, Netherlands, Norway, Peru, Poland, Romania, Swed... and more
-
AstraZenecaActive, not recruitingUrothelial CancerUnited States, Belgium, Denmark, Germany, Italy, Spain, Canada, Poland, Taiwan, France, Korea, Republic of, Netherlands, United Kingdom, Brazil, Japan, Mexico, Russian Federation, Turkey, China, Austria, Australia, Israel, Portugal, G...
-
Canadian Cancer Trials GroupCelgene; Australian and New Zealand Urogenital and Prostate Cancer Trials GroupCompletedUrothelial CancerCanada, Australia
-
University of FlorenceAzienda Ospedaliero-Universitaria CareggiRecruitingRecurrence | Surgery | Bladder Cancer | Muscle-Invasive Bladder Carcinoma | OncologyItaly
-
University of WashingtonBladder Cancer Advocacy NetworkRecruitingStage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
University of WashingtonGilead SciencesRecruitingStage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
University of WashingtonMerck Sharp & Dohme LLCRecruitingStage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
Istituto Clinico HumanitasUnknown
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingBladder Carcinoma | Kidney Carcinoma | Prostate Carcinoma | Genitourinary System NeoplasmUnited States
-
Universitätsklinikum Hamburg-EppendorfCancer Research UK; Deutsche Krebshilfe e.V., Bonn (Germany); Australasian Gastro-Intestinal... and other collaboratorsActive, not recruitingCholangiocarcinoma | Gall Bladder CarcinomaGermany, Netherlands, United Kingdom, Australia, Denmark, Italy, New Zealand, Austria
-
H. Lee Moffitt Cancer Center and Research InstituteCG Oncology, Inc.; Richard M. Shulze Family FoundationActive, not recruitingBladder Cancer | Muscle-Invasive Bladder CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral... and other conditionsUnited States
-
Cairo UniversityRecruitingMuscle-Invasive Bladder CarcinomaEgypt